GLAXOSMITHKLINE PLC's ticker is GSK and the CUSIP is 37733W105. A total of 805 filers reported holding GLAXOSMITHKLINE PLC in Q3 2019. The put-call ratio across all filers is 0.81 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2020 | $4,389,000 | -56.9% | 115,860 | -51.4% | 0.48% | -11.9% |
| Q3 2019 | $10,178,000 | +137.7% | 238,479 | +122.9% | 0.54% | +227.7% |
| Q2 2019 | $4,281,000 | +6.1% | 106,978 | +10.7% | 0.17% | -28.8% |
| Q1 2019 | $4,036,000 | +25.3% | 96,600 | +29.3% | 0.23% | +385.4% |
| Q2 2017 | $3,221,000 | -42.7% | 74,700 | -42.7% | 0.05% | -74.2% |
| Q3 2016 | $5,624,000 | +84.0% | 130,400 | +72.9% | 0.19% | +25.7% |
| Q1 2016 | $3,057,000 | +341.8% | 75,400 | +402.7% | 0.15% | +124.2% |
| Q1 2015 | $692,000 | +5.3% | 15,000 | +4.9% | 0.07% | -48.0% |
| Q3 2014 | $657,000 | +21.9% | 14,300 | +41.6% | 0.13% | +388.5% |
| Q1 2014 | $539,000 | +98.2% | 10,100 | +98.0% | 0.03% | 0.0% |
| Q4 2013 | $272,000 | -85.9% | 5,100 | -86.8% | 0.03% | -92.4% |
| Q2 2013 | $1,928,000 | – | 38,600 | – | 0.34% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| OSTERWEIS CAPITAL MANAGEMENT INC | 1,948,915 | $79,029,000 | 4.59% |
| Chubb Ltd | 400,000 | $16,220,000 | 4.42% |
| Pegasus Partners Ltd. | 172,275 | $6,986,000 | 3.79% |
| Keystone Financial Planning, Inc. | 117,762 | $4,775,000 | 3.42% |
| P.R. Herzig & Co. Inc. | 36,950 | $1,498,000 | 3.28% |
| Sterneck Capital Management, LLC | 112,535 | $4,563,000 | 3.21% |
| Hamlin Capital Management, LLC | 1,454,031 | $58,961,000 | 2.98% |
| Healthcare Value Capital, LLC | 50,000 | $2,028,000 | 2.98% |
| Jolley Asset Management, LLC | 80,639 | $3,270,000 | 2.98% |
| JFB Holdings Corp | 2,415,570 | $97,951,000 | 2.91% |